Neuroplasticity
Neuronal adaptation, synaptic plasticity and repair mechanisms.
Peptides linked to this mechanism
Oxytocin is an endogenous signalling peptide with physiological relevance; therapeutic administration remains molecule- and indication-specific.
Dihexa is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.
p21 is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.
Selank is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.
Pinealon is an organ-associated short peptide promoted for regulatory effects, but independent modern clinical evidence is sparse.
Galanin is an endogenous peptide with established physiological or receptor-level biology; therapeutic administration and indications are molecule-specific.
Semax is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.
NAP Peptide is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials.
A short endogenous angiotensin fragment studied mainly for learning, memory, cerebral blood flow and insulin-regulated aminopeptidase biology.
Endomorphin 1 is an endogenous peptide with established physiological or receptor-level biology; therapeutic administration and indications are molecule-specific.
Endomorphin 2 is an endogenous peptide with established physiological or receptor-level biology; therapeutic administration and indications are molecule-specific.